Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
Public ClinicalTrials.gov record NCT04723394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase III study will assess whether AZD7442 (a combination of 2 mAbs) can safely treat outpatient adults with COVID-19 and prevent either severe COVID-19 or death.
Study identification
- NCT ID
- NCT04723394
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 910 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2021 (Actual)
- Primary completion
- Aug 21, 2021 (Actual)
- Completion
- Oct 19, 2022 (Actual)
- Last update posted
- Jul 5, 2023
2021 – 2022
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Jasper | Alabama | 35501 | — |
| Research Site | Tucson | Arizona | 85704 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Northridge | California | 91324 | — |
| Research Site | Cutler Bay | Florida | 33157 | — |
| Research Site | Miami | Florida | 33125 | — |
| Research Site | Miami | Florida | 33165 | — |
| Research Site | Pompano Beach | Florida | 33064 | — |
| Research Site | Chicago | Illinois | 60621 | — |
| Research Site | Lake Charles | Louisiana | 70601 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | La Vista | Nebraska | 68128 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Charlotte | North Carolina | 28208 | — |
| Research Site | Charlotte | North Carolina | 28277 | — |
| Research Site | Statesville | North Carolina | 28625 | — |
| Research Site | Fargo | North Dakota | 58104 | — |
| Research Site | Columbus | Ohio | 43213 | — |
| Research Site | West Columbia | South Carolina | 29169 | — |
| Research Site | Dallas | Texas | 75235 | — |
| Research Site | Houston | Texas | 77027 | — |
| Research Site | Houston | Texas | 77057 | — |
| Research Site | Houston | Texas | 77093 | — |
| Research Site | Humble | Texas | 77338 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04723394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04723394 live on ClinicalTrials.gov.